Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC)
Autor: | Kathy D. Miller, B. J. Klencke, Meghna Samant, Nancy E. Davidson, Maura N. Dickler, Tamara Shenkier, Suman Bhattacharya, E. A. Perez, Julie Gralow, Melody A. Cobleigh |
---|---|
Rok vydání: | 2008 |
Předmět: | |
Zdroj: | Journal of Clinical Oncology. 26:1036-1036 |
ISSN: | 1527-7755 0732-183X |
Popis: | 1036 Background: E2100 was an open-label, multi-center, randomized, Phase III trial comparing P to P+B as initial chemotherapy for MBC. The original analysis based on investigator-assessed progress... |
Databáze: | OpenAIRE |
Externí odkaz: |